Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport

scientific article published in June 1990

Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0006-8993(90)90062-G
P698PubMed publication ID2118823

P50authorSalvatore MonacoQ48356915
Pierluigi GambettiQ56863357
Lucila Autilio-GambettiQ110527603
P2093author name stringL M Sayre
A Patton
T Wongmongkolrit
C M Shearson
B Schaetzle
P2860cites workAlterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposureQ23910046
P433issue1-2
P407language of work or nameEnglishQ1860
P304page(s)73-81
P577publication date1990-06-01
P1433published inBrain ResearchQ4955782
P1476titleGiant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport
P478volume519

Reverse relations

cites work (P2860)
Q443204372,5-Hexanedione-induced intermediate filament aggregates contain ubiquitin-protein conjugate immunoreactivity and resemble Rosenthal fibres
Q73585233Alteration in neurofilament axonal transport in the sciatic nerve of the diisopropyl phosphorofluoridate (DFP)-treated hen
Q80497038Axonopathy-inducing 1,2-diacetylbenzene forms adducts with motor and cytoskeletal proteins required for axonal transport
Q45951628Comparative covalent protein binding of 2,5-hexanedione and 3-acetyl-2,5-hexanedione in the rat.
Q68027608Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro
Q72546231Effect of exposure to 2,5-hexanediol in light or darkness on the retina of albino and pigmented rats. II. Electrophysiology
Q34841278Fast axonal transport: a site of acrylamide neurotoxicity?
Q48412554Giant axonal neuropathy with subclinical involvement of the central nervous system: case report.
Q28370059Mechanisms of toxic injury in the peripheral nervous system: neuropathologic considerations
Q38925500Metabolomics and mass isotopomer analysis as a strategy for pathway discovery: pyrrolyl and cyclopentenyl derivatives of the pro-drug of abuse, levulinate.
Q40444777Pathogenetic studies of hexane and carbon disulfide neurotoxicity
Q40750866Probing modifications of the neuronal cytoskeleton
Q38075085Toxic neurofilamentous axonopathies -- accumulation of neurofilaments and axonal degeneration
Q44652910γ-diketone central neuropathy: quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots

Search more.